reported side effects of canagliflozin
vulvovaginal candidiasis
vaginal infection
vulvitis
vulvovaginitis
glomerular filtration rate
other side effects
balanitis
balanoposthitis
urine output
nocturia
polyuria
urinary urgency
pollakiuria
comprehensive list of adverse effects
reported adverse reactions
hypoglycemia
combination with insulin
insulin secretagogue
vulvovaginal candidiasis
urinary tract infection
urinary frequency
female genital mycotic infections
vulvovaginal mycotic infection
vulvovaginitis
vaginal infection
vulvitis
genital infection
recurrent male genital mycotic infections
urinary tract infection
urination
male genital mycotic infections
balanitis
balanoposthitis
balanitis candida
fungal genital infection
phimosispostmarketing reports
urosepsis
pyelonephritis
adverse reactions
reduced intravascular volume
postural hypotension
orthostatic hypotension
hypotension
dehydration
syncope
reports of acidosis
us food
drug administration
adverse event reporting system
faers
database during the period march through june
patients
emergency room treatment
hospitalization
cases
ketoacidosis
diabetic ketoacidosis
dka
patients with type diabetes
blood sugar levels
factors
triggering
acidosis
major illness
food
fluid intake
insulin dose
hypoglycemia
insulin
insulin secretagogue
hyperkalemia
increased serum magnesium
serum phosphate
low-density lipoprotein
ldl-c
postmarketing reports
acidosis
diabetic ketoacidosis
ketoacidosis
ketosis
constipation
thirst
nausea
abdominal pain
pancreatitis
pooled analysis of clinical trials with a mean duration drug exposure of weeks
incidence rate
adjudicated bone fractures
patient years of exposure
comparator
mg dose
fractures
weeks
low trauma
upper extremities
september
us food
drug administration
drug safety communication
regarding new information on bone fracture risk
bone mineral density with use of canagliflozin
updated data
fractures
weeks
starting therapy with trauma
falling
standing height
year study
n =-rrb-
greater loss of bone mineral density at the hip
lower spine in canagliflozin
treated patients
placebo
bone fracture
upper extremity fracturefrequency
loss of bone mineral density at hip
lower spine
hypersensitivity reactions
rash
pruritus
urticaria
angioedemafrequency
serious hypersensitivity reactionpostmarketing reports
anaphylaxis
frequency
increases in serum creatinine
egfr
renal impairment
acute renal failurepostmarketing reports
acute kidney injury
pooled analysis among patients with moderate renal impairment
incidence of renal related adverse reactions
increased serum creatinine
egfr
renal impairment
acute renal failure
patients
receiving canagliflozin mg
mg
receiving comparator drug
placebo
march
october
us fda
confirmable case reports of acute kidney injury
aki
use of canagliflozin
n =-rrb-
dapagliflozin
n =-rrb-
hospitalization
evaluation
management in cases
admission
intensive care unit
cases
death
patients
dialysis
patients
history of chronic kidney disease
previous aki
cases
time
onset of aki
month
initiating therapy
cases in which drug discontinuation
subsequent improvement
patients
sequelae
patients
including
deaths
median age
years
range
years
cases
reporting age
concomitant ace inhibitor therapy
cases
diuretic use in cases
nsaid use in cases
patients
change in renal function at time of diagnosis
median elevation of serum creatinine from baseline mg/dl
cases
reporting serum creatinine
median decrease in egfr ml/min/m
cases
reporting egfr
photosensitivity reactions
rash
urticaria
us fda
safety
alert warning
increased leg
foot amputations
toes
placebo in the ongoing canvas
canagliflozin cardiovascular assessment study
clinical trial
interim safety results
shown risk of amputation for patients
receiving mg
mg
placebo
patients
average follow-up of years
similar trial
canvas-r
trial
risks
average follow-up months
fda
safety issue
fatigue
asthenia
fallsuncommon
leg
foot amputations
bladder pain
cloudy urine
decreased frequency
amount of urine
burning
painful urination
discharge with a strong odor from the penis
frequent urge
increased thirst
itching of the vagina
outside of the genitals
loss of appetite
side pain
nausea
pain during sexual intercourse
pain in the skin around the penis
redness
itching
swelling of the penis
swelling of the face
fingers
lower legs
troubled breathing
unusual tiredness
weakness
vaginal discharge without odor
mild odor
vomiting
weight gain
anxiety
blurred vision
chills
cold sweats
confusion
cool, pale skin
depression
dizziness
dry mouth
irregular heartbeat
headache
hives
welts
itching skin
rash
increased hunger
hive-like swelling on the face
eyelids
lips
tongue
throat
hands
legs
feet
sex organs
nightmares
redness of the skin
seizures
shakiness
slurred speech
unusual tiredness
weakness
stomach pain
blurred vision
dizziness
faintness
lightheadedness
getting
lying
sitting position
flushed, dry skin
painful urination
frequent urge
fruit-like breath odor
increased urination
loss of consciousness
numbness
tingling in the hands
feet
lips
stomach pain
sweating
unexplained weight loss
weakness
heaviness of the legs
difficulty
bowel movement
stool
lack
loss of strength
pain
swelling in the arms
legs without an injury
increased sensitivity of the skin
sunlight
redness
other discoloration of the skin
severe sunburn